This post was created on the 22nd of November 2020 because I think the stock is getting to a strong momentum stage with major short-medium term catalysts. With only 1% market penetration, annual earnings of 360M from IHL-42X alone. This buyout had two huge ramifications for the industry. Others are either selling different types of products or are too inferior to IHL. Only reason it didn't go higher is because of profit takers which is fair enough. Assuming 1% of target is 10M users. Overhead resistance at 25.5 which will need a couple of recoils to get through, but once through should see new highs quite easily. The share price would be there at 25c. Cheers. Great write up. It is worth researching previous in-human clinical trials involving dronabinol for OSA, such as the Carley Trial and RespireRX’s trial. He helped promote the story of FMG to US institutions and investors, and raised capital to clear the debt of FMG. Do yourself a favor and read it. Peter Widdows deserves a little note here, he was formerly head of Heinz Asia/Pacific which was a multi-billion dollar corporation and has extensive experience in sales at a regional level. Trying to Balance out our lost super one bunnings sausage at a time. . The company is engaging in LSD assisted therapy for anxiety, and is currently in Phase 2A of clinical development. IHL is currently in progress with an animal In Vivo study for the IHL-216A program. Canary is a dark horse, considering what they did for 3DP by bringing Bevan Slattery to the register I can only imagine they could do something similar for IHL. IHL is similar in that they are targeting markets such as ARDS, Obstructive Sleep Apnea, Traumatic Brain Injury and Asthma with TAM over $1B each. The standard IHL could meet is a 200M USD global market capitalization. Why the Incannex Healthcare (ASX:IHL) share price is up 15% today msn.com - February 16 at 8:54 AM: Why the Incannex (ASX:IHL) share price is soaring 13% msn.com - February 11 at 10:17 AM: Why the Tilt (ASX:TLT) share price just broke its record high fool.com.au - February 5 at 6:16 PM: The Incannex (ASX:IHL) share price is surging 7% higher today. Psychedelics, for those who know a bit about its history and evolution, has had a strong history of research and efficacy and it is now resurging. I dont understand that. Examining Impression Healthcare Limited’s (ASX:IHL) past track record of performance is an insightful exercise for investors. Press J to jump to the feed. Very little overseas re companies playing in the sector - and a lot of these are "aspirational". As of time of drafting, the SP of IHL is 22c, but I will be posting this on 17/02/2021. I … Is it one of the ex Directors from when IHL was a mouthguard company? This thought is backed by the decision of IHL to create novel cannabinoid drugs in areas where there is no existing pharmacotherapy. This would be $1.28B AUD. Health & Biotech. Thanks for such a comprehensive DD mate. If IHL is successful at dual-listing on the NYSE or NASDAQ, I would consider them a US stock and they should be valued as such. This is not financial advice, only my opinion. He is also a multimillion share T20 holder in ADN and NVA among other stocks, and bought ADN at 0.003. Need to add "for this one trick" to the end of it for better context. Compass has over 10 bagged since IPOing in September 2020. https://ir.compasspathways.com/static-files/542bb3a1-c0e6-4f1b-87fa-5fd4f2fb7a6d. Not the shitty OTC markets that barely have any impact on their ASX counterparts, but a main market like the NYSE or the NASDAQ. etc will lead to a ban of the mods chosing. See you at $1 . Confusing. IHL is engaging in a similar task with its psilocybin assisted therapy for anxiety, and will certainly seek out the FDA for a Pre-IND meeting just like MindMed when the time is right. You can find it here. He is the former head of Ellerston Capital, a multibillion dollar fund and currently heads Gannet Capital. CARA is a clinical stage cannabinoid biotech company, which boasts a valuation of $1B USD. I don't hold but I hope it does well! Broker data for IHL segmented as a chart overly for context. 67.3k members in the ASX_Bets community. . Can't say I have a deep understanding of dual-listing in the US but this was pretty clear. US Investors understand this, and in my view far more than the ASX which loves the big banks and digging metal out of the ground. They are in it for bags not pips. Brilliant track record. Green period is 30 June to 15 July. ASX Announcements and Latest News from INCANNEX HEALTHCARE LIMITED. Trying to … Furthermore, the company notably is the best performer amongst the entire medicinal cannabis sector and went from a mouthguard company under 20M MC to the highest valued ASX listed MM stock in 2 years while the entire sector went backwards down the shitter. Good green buying volume in past week, could be signs of news, could also just be general positive valuation in company. Wait till you tell them this is a phama company that has been able to launch in the asx and make revenues before tga/fda approval and get real world data even before formal trials massively reducing risk. The inference can be made that IHL-675A is up to 767% times superior to ARDS-003. There are very few recognised experts in this field and Paul Liknaitzky is the leading authority in Australia. The 25c options indicate that Canary believes that the SP will be at least 30c, if not there is no value at being able to get liquidity for shares at 25c. Incredibly strong buying and barely any selling. Desperately seeking Purge. How many ? There is a clear connection between the two companies, and Cannvalate has significant skin in the game in IHL, ensuring that Dr Sud’s interests remain with the company. Traumatic Brain Injury is another multi-billion dollar market with no existing pharmacotherapy, and IHL has appointed Liam Picken (AFL) and James Graham (NRL) to the advisory board for the TBI program. Huge SOI preventing any future material share price gain. Is 13c now. https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02224918-3A539368?access_token=83ff96335c2d45a094df02a206a39ff4, https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02312153-3A556096?access_token=83ff96335c2d45a094df02a206a39ff4, https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02218148-3A538119?access_token=83ff96335c2d45a094df02a206a39ff4, https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02227653-3A539896?access_token=83ff96335c2d45a094df02a206a39ff4, https://www.smh.com.au/business/small-business/investor-buzz-around-cannabis-stocks-with-new-treatments-20200924-p55ypc.html, https://www.goodreads.com/book/show/13604147-bulls-bears-a-croupier. IHL has assembled a world class team, with top tiers across all roles. https://www.reddit.com/r/ASX_Bets/comments/jz5jm8/asxihl_incannex_healthcare_biotechmedicinal/ In at 0.18 - looking forward to the progress of their trials, it’s really interesting! Iron Ore Crude Oil Gold Silver Copper All Commodities ≫ Popular Pages. Feeling better about the losses I’ve copped since buying at .27. A more updated and comprehensive writeup was written by a friend of mine, who is a professional trader and in the stockbroking industry who posted this massive writeup January 2021. Cheers and great write up. For those unaware of IHL, I made a public summary in November 2020 on both reddit and HC back when the SP was 11.5c. Subs like r/MindMedInvestorsClub & r/shroomstocks are fomenting interest, making this a pretty volatile sector right now (perfect for degenerate gamblers like myself). From the Annual Report he held 20M IHLOB which he converted, and has bought millions more on market since. Before I begin this post, (this was initially designed for reddit but will be posted on HC too). https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02224918-3A539368?access_token=83ff96335c2d45a094df02a206a39ff4. We use cookies on our websites for a number of purposes, including analytics and performance, functionality and advertising. A successful meeting with the FDA here would be immensely valuable to the future. https://www.reddit.com/r/ASX_Bets/comments/jz5jm8/asxihl_incannex_healthcare_biotechmedicinal/. For reference, the FDA has approved Tetra Biopharma for human trials with COVID-19 for their drug ARDS-003, which is synthetic CBD. This doubles as incentives but also as a source of future funding. IHL is currently undertaking 4 significant clinical programs to develop 4 uniquely formulated products in its relentless pursuit of FDA registration and market exclusivity over the following indications: Obstructive Sleep Apnoea (‘OSA’) Traumatic Brain Injury (‘TBI’)/Concussion Sepsis Associated Acute Respiratory Distress Syndrome (‘SAARDS’) Temporomandibular Joint Disorder (‘TMJD’). This would be $1.16B AUD. This kind of top tier executive does not belong on a penny stock spec board. Cannvalate is IHL’s #1 shareholder, and shares its CEO Dr Sud Agarwal as IHL’s CMO. In AUD, this would mean 257M. That’s only the half of it. Full Announcement can be found here. https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02227653-3A539896?access_token=83ff96335c2d45a094df02a206a39ff4. Thanks mate, should consolidate at these levels for a bit before further news :), I dont have time to read all this shit, someone tell me how many rockets expected. Compass Pathways on the NASDAQ is perhaps the only real major player and they recently listed and now have a $1.3B market cap. A market cap over 200 million made up of promises and generic oil sales. Depression treatment innovation & psychedelic trials will be a very interesting play over the next few years. IHL has only recently surpassed the $100M MC level and is still very undiscovered. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. IHL is actually about to meet with the FDA along with their consultants Camargo for a Pre-IND meeting regarding their drug IHL-675A for ARDS. Canary Capital is notorious for getting placements and did not receive one to take a position in IHL. Canary is IHL’s Corporate Advisor, and in exchange for their services in lieu of cash, Canary has been granted 10M options with a 15c strike, and 10M options with a 25c strike. However, with new advancements into the psychedelics sphere and the decision to engage further in markets such as Asthma IHL is expanding its horizons significantly. Should’ve jumped on them at open! **Dr Sud Agarwal (Non-Exec Director & CMO)**, • 5,600,000 fully paid ordinary shares (“IHL”), • 200,000,000 $0.20 unlisted options expiry 30-Sep-21, • 32,000,000 fully paid ordinary shares (“IHL”), • 14,000,000 $0.06 unlisted options expiry 01-Dec-20, • 16,000,000 $0.08 unlisted options expiry 01-Dec-20, • 18,000,000 $0.10 unlisted options expiry 01-Dec-20, • 20,000,000 $0.12 unlisted options expiry 01-Dec-20, • 20,000,000 $0.14 unlisted options expiry 01-Dec-20. If I hadn’t already gone all in on this stock I would now. Press question mark to learn the rest of the keyboard shortcuts. Cannvalate is IHL’s #1 shareholder, and shares its CEO Dr Sud Agarwal as IHL’s CMO. Been riding this since 13c sold just under half and practically free riding. The BOD are all Top 20 holders, and all participated in the IHLOB program to raise $10M in funds, contributing $1.2M of their own money towards the company. From my understanding, Canary started accumulating stock in the 6-8c range initially and has continued to buy even up to current prices. You can find this writeup here. There are no existing competitors to IHL-42X pharmacotherapy, unlike Cochlear. This would allow IHL to meet with the FDA for an IND. IHL is looking good. A lot of you already know this, but Next Investors is one of three "promotion groups", the other two being Catalyst Hunter and Wise Owl, that fall under the umbrella of Stocks Digital.This is something that confused me at first, but makes a little sense according to their "philosophy".Catalyst hunter is for their short term, Next Investors for mid term, and Wise Owl for long term plays. Cannvalate’s dominance as the #1 medicinal cannabis distributor in Australia plays an enormous role in IHL's growth in this area. IHL is not taking on too much debt commitment, which can be restrictive and risky for equity-holders. It's so weird that all the high-quality posts are on r/ASX_Bets. The BOD totals four. This is because IHL is cashed up. Good green buying volume in past week, could be signs of news, could also just be general positive valuation in company. Eddie and EAS are incentivized by IHL with 10M 20c options and 10M 25c options. Incannex Healthcare (ASX:IHL) Frequently Asked Questions What stocks does MarketBeat like better than Incannex Healthcare? There is also Mr Anthony Malyniak the #3 shareholder as per the 2020 Annual Report, now likely to be lower in the list who from my understanding is a Hartley’s client. Cannvalate is Australia’s largest medicinal cannabis distributor, with close to 50% total market share. Their track record includes the likes of CRO, HTG and 3DP which are all 10 baggers from when Canary entered the register. IHL has recently appointed Dr Paul Liknaitzy to the medical advisory board for 18 months. I wrote a summary DD on IHL a few months back, this is more detailed and up to date. Furthermore, the company notably is the best performer amongst the entire medicinal cannabis sector and went from a mouthguard company under 20M MC to the highest valued ASX listed MM stock in 2 years while the entire sector went backwards down the shitter. It will have COVID-19, HCQ, CBD and FDA in the wording. Biggest blue balls on the ann today, WHERE IS IT!? Their position, investing style and extremely good track record speak for themselves. Let's begin. You can find this writeup here. These are the same ones pumping it on HC and here. IHL has a massive opportunity to be a global leader here. I have to sit this one out though, I have an intense distaste of someone formerly involved with the company, so my spite/ego won't let me enter in to anything he's touched. An Australian equivalent to /r/Wallstreetbets , the madness starts here. He has been there for years and has been buying consistently. Likely delayed for resubmission. Presumably for Necrophilia purposes. The potential of the clinical programs at work here is enormous, ARDS is probably the most headlined condition of 2020 due to COVID-19 and IHL could have the answer. And my axe. If you initially designed this for reddit where are the rocket emojis? As of 23/11/2020, IHL and Camargo are seeking a Pre-IND meeting with the FDA, where they will request an EUA from the FDA and guidance from the FDA on how to achieve this. Today’s IHL share price, stock chart and announcements. View dividend history, insider trades and ASX analyst consensus. It is not mentioned at all on reddit r/ASX_Bets either. Find market predictions, IHL financials and market news. Full Announcement can be found here. IHL has achieved parabolic sales quarter on quarter since inception of the Incannex Brand late 2019. IHL:ASX price reached a new 52-week high of 0.325 at 11:04 BST May 03 2021 Key statistics On Friday, Incannex Healthcare Ltd (IHL:ASX) closed at 0.305, -8.96% below its 52-week high of 0.335, set on May 03, 2021. Really interesting. IHL mainly engages in cannabinoid drug development, and also in psychedelics endeavours. Initial stats are taken from Resmed, whose CPAP is currently the leading treatment for OSA. The company is currently recruiting patients and is expected to commence soon. IHL has recently finished a multi stage preclinical trial consisting of two in vitro and two in vivo studies. Each represents a multi-billion dollar market with no existing pharmacotherapy. Others in the Top 20 that aren’t the Board, Cannvalate, Glenn Poswell or Canary Capital clients are of note here. As of the latest Annual Report, Mr Peter Proska also known as The Croupier of the “Bulls, Bears and a Croupier” fame holds 12M IHLOB which he converted. Eddie is a prominent Jewish Banker based in New York City, who has an incredibly extensive network and is tasked by IHL with facilitating introductions to US banks and institutions, with the aim of dual listing IHL on a US Main Market (NYSE/NASDAQ). IHL appointed EAS Advisors LLC to facilitate a US listing on a MAIN MARKET. Fuck him, and good luck to the rest of you. Thus they should be considered to be both types of companies. Recovery period in blue is 20 July to 18 September. Whilst a very long ways off from GW Pharma and their achievements, it is obvious what IHL is attempting to do. I really appreciate the effort you go to. Direct + Indirect (Ekirtson, Tranaj, Valplan, Alignment, Cityside), • 7,116,950 unlisted $0.08 options expiry 30-Sep-21, • 200,000 unlisted $0.08 Options expiry 30-Sep-21, • 4,119,285 IHL fully paid shares (voluntary escrow), • 657,895 unlisted $0.08 Options expiry 30-Sep-21. Eddie knew Twiggy Forrest from their time together at Anaconda, and when Twiggy and FMG seemed to be in a dire situation and required capital and interest from overseas when none locally would back a seemingly failed entrepreneur like himself, Eddie stepped up to deliver. If you need someone to hold your hand and wipe your mouth then go to a different post and trade your baby parcels elsewhere. Eddie and the US Investors in his network were more than happy to support Twiggy, taking on more risk than most would be willing to chew investing in what was at the time a speculative mining company in Western Australia on the brink of being crippled by debt and unable to raise capital to continue further. Furthermore, the risk/reward at these levels is excellent value. I'm heavily invested in MGC Pharmaceuticals (ASX: MXC) also recently listed on the London stock exchange. As per the title of the post, there is a lot that has happened with IHL over the past few months. MindMed boasts a valuation of $900M USD, and had highs of $1.27B USD. The former three have no existing pharmacotherapy and therefore no drug related competition. This thread is for plans and thoughts prior to the market open period. HotCopper has news, discussion, prices and market data on INCANNEX HEALTHCARE LIMITED. Great write up mate. Impression Healthcare (ASX: IHL) has changed its name to Incannex Healthcare - IHL (ASX: IHL). For OSA, IHL is currently recruiting for a Phase 2B human trial and looks to commence that imminently. Eddie can boast the likes of Twiggy and other billionaires in his network, and it is completely warranted to say that for a small cap stock on the ASX, this is almost unheard of.